Effects of combined treatment with zibotentan and dapagliflozin compared to dapagliflozin alone on insulin resistance and markers of inflammation

Victor Wasehuus; Johannes David Smeijer; M Sayer; Phil Ambery; Peter J Greasley; Emma Wijkmark; S Cigarran; José Luis Górriz; Maria Jose Soler; Peter Rossing; Hiddo J.L. Heerspink

doi:10.1007/s00125-025-06497-1

Effects of combined treatment with zibotentan and dapagliflozin compared to dapagliflozin alone on insulin resistance and markers of inflammation

Victor Wasehuus, Johannes David Smeijer, M Sayer, Phil Ambery, Peter J Greasley, Emma Wijkmark, S Cigarran, José Luis Górriz, Maria Jose Soler, Peter Rossing, Hiddo J.L. Heerspink

Steno Diabetes Center Copenhagen

Original language	English
Article number	514
Journal	Diabetologia
Volume	68
Issue number	Suppl 1
Pages (from-to)	S266
ISSN	0012-186X
DOIs	https://doi.org/10.1007/s00125-025-06497-1
Publication status	Published - Oct 2025
Event	61th EASD Annual Meeting: EASD 2025 - Wien, Austria Duration: 15 Sept 2025 → 19 Sept 2025

Conference

Conference	61th EASD Annual Meeting: EASD 2025
Country/Territory	Austria
City	Wien
Period	15/09/2025 → 19/09/2025

Access to Document

10.1007/s00125-025-06497-1Licence: Unspecified

Cite this

Wasehuus, V., Smeijer, J. D., Sayer, M., Ambery, P., Greasley, P. J., Wijkmark, E., Cigarran, S., Górriz, J. L., Soler, M. J., Rossing, P., & Heerspink, H. J. L. (2025). Effects of combined treatment with zibotentan and dapagliflozin compared to dapagliflozin alone on insulin resistance and markers of inflammation. Diabetologia, 68(Suppl 1), S266. Article 514. https://doi.org/10.1007/s00125-025-06497-1

Effects of combined treatment with zibotentan and dapagliflozin compared to dapagliflozin alone on insulin resistance and markers of inflammation. / Wasehuus, Victor; Smeijer, Johannes David; Sayer, M et al.
In: Diabetologia, Vol. 68, No. Suppl 1, 514, 10.2025, p. S266.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Wasehuus, V, Smeijer, JD, Sayer, M, Ambery, P, Greasley, PJ, Wijkmark, E, Cigarran, S, Górriz, JL, Soler, MJ, Rossing, P & Heerspink, HJL 2025, 'Effects of combined treatment with zibotentan and dapagliflozin compared to dapagliflozin alone on insulin resistance and markers of inflammation', Diabetologia, vol. 68, no. Suppl 1, 514, pp. S266. https://doi.org/10.1007/s00125-025-06497-1

@article{ff476fcc169a46608fa1659ac622a34b,

title = "Effects of combined treatment with zibotentan and dapagliflozin compared to dapagliflozin alone on insulin resistance and markers of inflammation",

author = "Victor Wasehuus and Smeijer, \{Johannes David\} and M Sayer and Phil Ambery and Greasley, \{Peter J\} and Emma Wijkmark and S Cigarran and G{\'o}rriz, \{Jos{\'e} Luis\} and Soler, \{Maria Jose\} and Peter Rossing and Heerspink, \{Hiddo J.L.\}",

year = "2025",

month = oct,

doi = "10.1007/s00125-025-06497-1",

language = "English",

volume = "68",

pages = "S266",

journal = "Diabetologia",

issn = "0012-186X",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "Suppl 1",

note = "61th EASD Annual Meeting: EASD 2025, EASD ; Conference date: 15-09-2025 Through 19-09-2025",

}

TY - ABST

T1 - Effects of combined treatment with zibotentan and dapagliflozin compared to dapagliflozin alone on insulin resistance and markers of inflammation

AU - Wasehuus, Victor

AU - Smeijer, Johannes David

AU - Sayer, M

AU - Ambery, Phil

AU - Greasley, Peter J

AU - Wijkmark, Emma

AU - Cigarran, S

AU - Górriz, José Luis

AU - Soler, Maria Jose

AU - Rossing, Peter

AU - Heerspink, Hiddo J.L.

PY - 2025/10

Y1 - 2025/10

U2 - 10.1007/s00125-025-06497-1

DO - 10.1007/s00125-025-06497-1

M3 - Conference abstract in journal

SN - 0012-186X

VL - 68

SP - S266

JO - Diabetologia

JF - Diabetologia

IS - Suppl 1

M1 - 514

T2 - 61th EASD Annual Meeting: EASD 2025

Y2 - 15 September 2025 through 19 September 2025

ER -